Abstract
Till now, across from a few basic data, nothing is well clear regarding its exact origin, incubation period, seriousness and what makes it transmissible is not recommended for COVID19 anywhere in the world. It was on 28 January, 2020 that the World Health Organisation released a paper relating to medical data and recommendations from the management of previous HCoV epidemics. The present paper outlines steps for the identification and assessment of patients with extreme acute respiratory disease; monitoring and infection prevention strategies; tracking and early intervention therapy; treatment of respiratory arrest and ARDS; clinical diagnosis; recommendations for septic shock management; therapies; and concerns for pregnant women.
Keywords: Fight against COVID19, health system, vaccine, treatment, drugs, ARDS.
Current Signal Transduction Therapy
Title:Impact of Covid19 and its Treatment: A Report
Volume: 16 Issue: 3
Author(s): Karan Veer and Tanu Sharma*
Affiliation:
- Department of Instrumentation and Control Engineering; Department of Computer Science and Engineering; Dr. B.R. Ambedkar National Institute of Technology, Jalandhar,India
Keywords: Fight against COVID19, health system, vaccine, treatment, drugs, ARDS.
Abstract: Till now, across from a few basic data, nothing is well clear regarding its exact origin, incubation period, seriousness and what makes it transmissible is not recommended for COVID19 anywhere in the world. It was on 28 January, 2020 that the World Health Organisation released a paper relating to medical data and recommendations from the management of previous HCoV epidemics. The present paper outlines steps for the identification and assessment of patients with extreme acute respiratory disease; monitoring and infection prevention strategies; tracking and early intervention therapy; treatment of respiratory arrest and ARDS; clinical diagnosis; recommendations for septic shock management; therapies; and concerns for pregnant women.
Export Options
About this article
Cite this article as:
Veer Karan and Sharma Tanu *, Impact of Covid19 and its Treatment: A Report, Current Signal Transduction Therapy 2021; 16 (3) . https://dx.doi.org/10.2174/1574362415999201223090332
DOI https://dx.doi.org/10.2174/1574362415999201223090332 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Milk Oligosaccharides and Lectins as Candidates for Clinical Trials against Covid-19
Current Nutrition & Food Science Sociodemographic Correlates of Coping Styles Among the General Population in Saudi Arabia During the COVID-19 Pandemic
Current Psychiatry Research and Reviews Synthesis, Cytotoxicity and Antimicrobial Activity of New Enmein-type Kauranoid Diterpenoid Derivatives
Anti-Cancer Agents in Medicinal Chemistry Metabolism of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy: A Review of the Literature
Current Drug Metabolism Advances in Drug Discovery based on Genomics, Proteomics and Bioinformatics (Part III)
Current Topics in Medicinal Chemistry Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Mini-Reviews in Medicinal Chemistry The Pilot Phase of the NIH Chemical Genomics Center
Current Topics in Medicinal Chemistry Computational Molecular Modeling of Compounds from Amaryllidaceae Family as Potential Acetylcholinesterase Inhibitors
Current Bioactive Compounds Identification of Novel Indazole-based Inhibitors of Fibroblast Growth Factor Receptor 1 (FGFR1)
Current Enzyme Inhibition Poloxamer 188 (P188) as a Membrane Resealing Reagent in Biomedical Applications
Recent Patents on Biotechnology Rubiscolins - Highly Potent Peptides Derived from Plant Proteins
Mini-Reviews in Medicinal Chemistry Structural and Modeling Studies on ecto-5’-nucleotidase Aiding in Inhibitor Design
Mini-Reviews in Medicinal Chemistry C. elegans as Model for Drug Discovery
Current Topics in Medicinal Chemistry Synthesis and Anti-HCV Activities of 18β-Glycyrrhetinic Acid Derivatives and Their In-Silico ADMET Analysis
Current Computer-Aided Drug Design SUBJECT INDEX TO VOLUME 1
Current Medicinal Chemistry - Anti-Cancer Agents New Ideas for a 160 Years-Old Reaction
Current Organic Synthesis Synthesis and Antimalarial Activity of Novel Side Chain Modified Antimalarial Agents Derived from 4-Aminoquinoline
Medicinal Chemistry New and Old Hot Drug Targets in Tuberculosis
Current Medicinal Chemistry Furocoumarins from Cnidium monnieri Act as Peroxisome Proliferatoractivated R and Farnesoid X Receptor Agonists
Mini-Reviews in Organic Chemistry Melanin-Concentrating Hormone Receptor 1 Antagonists: A New Perspective for the Pharmacologic Treatment of Obesity
Current Medicinal Chemistry